Alok Sonig
Corporate Officer/Principal chez BAXTER INTERNATIONAL INC.
Fortune : 4 M $ au 30/06/2024
Profil
Actuellement, Alok Sonig occupe le poste de CEO-US Generics, Global Head-R&D chez Lupin Ltd. et Président de Lupin Research, Inc. (une filiale de Lupin Ltd.). M. Sonig est également président et trésorier de l'Association for Accessible Medicines. Dans sa carrière antérieure, il a été PDG des marchés développés des États-Unis, de l'Union européenne et du Japon chez Dr. Reddy's Laboratories Ltd. et directeur général de Bristol-Myers Squibb India Pvt Ltd. M. Sonig a obtenu un diplôme de premier cycle du Punjab Engineering College et un MBA de l'American University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/03/2024 | 113 454 ( 0,02% ) | 4 M $ | 30/06/2024 |
Postes actifs de Alok Sonig
| Sociétés | Poste | Début |
|---|---|---|
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/06/2022 |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Président | - |
Lupin Research, Inc.
 Lupin Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Lupin Research, Inc. is a company that manufactures and commercializes pharmaceutical products. The company is based in Baltimore, MD. | President | - |
Anciens postes connus de Alok Sonig
| Sociétés | Poste | Fin |
|---|---|---|
| LUPIN LIMITED | Directeur Technique/Scientifique/R&D | 01/06/2022 |
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01/08/2018 |
Bristol-Myers Squibb India Pvt Ltd.
 Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. is an Indian company that discovers, develops, and delivers medicines for immuno-oncology. The company is based in Mumbai, India. | Corporate Officer/Principal | 01/05/2012 |
Formation de Alok Sonig
| Punjab Engineering College | Undergraduate Degree |
| American University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| LUPIN LIMITED | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bristol-Myers Squibb India Pvt Ltd.
Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. is an Indian company that discovers, develops, and delivers medicines for immuno-oncology. The company is based in Mumbai, India. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Lupin Research, Inc.
Lupin Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Lupin Research, Inc. is a company that manufactures and commercializes pharmaceutical products. The company is based in Baltimore, MD. | Health Technology |
